Private Advisor Group’s Ovid Therapeutics OVID Stock Holding History

Private Advisor Group’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.4K	Buy	+13,175	New	+$34K	﹤0.01%	2480
2025 Q4	–	Sell	-25,600	Closed	-$33.3K	–	2726
2025 Q3	$33.3K	Buy	+25,600	New	+$22.2K	﹤0.01%	2476
2020 Q3	–	Sell	-1,880	Closed	-$14K	–	2859
2020 Q2	$14K	Buy	+1,880	New	+$8.79K	﹤0.01%	2763

Other funds holding OVID

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SFG

Sovereign Financial Group Stamford, Connecticut $654M AUM 32.34% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

BMC

Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

TFM

TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return

Private Advisor Group's OVID Position: Q2 2026 in Review

Private Advisor Group opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 13,175 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #2480 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in OVID as recently as Q3 2025.

Private Advisor Group first reported a position in OVID in Q2 2020 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

Private Advisor Group held 13,175 shares of Ovid Therapeutics worth $35.4K as of Q2 2026.
Ovid Therapeutics was a new Private Advisor Group position in Q2 2026.
Ovid Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2480 holding.
Private Advisor Group first reported a position in Ovid Therapeutics in Q2 2020 and has held it in 3 quarters since.
14 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.